CELEX: 52010PC0397
Language: da
Date: 2010-07-27
Title: Forslag til EUROPA-PARLAMENTETS OG RÅDETS FORORDNING om sikring af toldfri behandling af visse aktive farmaceutiske ingredienser på WHO's liste over internationale ikke-navnebeskyttede navne (INN) og af visse produkter, der anvendes til fremstilling af farmaceutiske færdigvarer, og om ændring af bilag I til forordning (EØF) nr. 2658/87

|

52010PC0397

	[pic] | EUROPA-KOMMISSIONEN |Bruxelles, den 27.7.2010KOM(2010)397 endelig2010/0214 (COD)Forslag tilEUROPA-PARLAMENTETS OG RÅDETS FORORDNINGom sikring af toldfri behandling af visse aktive farmaceutiske ingredienser på WHO's liste over internationale ikke-navnebeskyttede navne (INN) og af visse produkter, der anvendes til fremstilling af farmaceutiske færdigvarer, og om ændring af bilag I til forordning (EØF) nr. 2658/87BEGRUNDELSEReferatet af drøftelserne om handelen med farmaceutiske produkter (Record of Discussions of the Trade in Pharmaceutical Products) er en ordning mellem de vigtigste lægemiddelproducerende lande om at reducere deres WTO-toldbindinger på visse lægemidler til nul og på MFN-basis, herunder aktive farmaceutiske ingredienser og mellemstoffer. Aftalens parter er EU, USA, Japan, Canada, Schweiz, Norge og Macao (Kina).Ordningen omfattede oprindeligt over 6 000 produkter. Da der hele tiden udvikles nye farmaceutiske produkter, er det ifølge ordningen hensigten, at disse produkter med jævne mellemrum tages op til revision. Parterne blev enige om, at mødes inden for rammerne af WTO's Råd for Handel med Varer, sædvanligvis mindst én gang hvert tredje år, for at revidere produktdækningen med henblik på ved konsensus at tilføje yderligere farmaceutiske produkter, der ikke længere skal belægges med told. Dækningen blev første gang revideret i 1995-1996, hvilket resulterede i, at yderligere 465 produkter blev fritaget for told. Efter den anden revision i 1998 (gennemført i juli 1999) blev endnu 639 produkter fritaget for told. Med den tredje revision i 2006 blev yderligere 1 290 produkter fritaget.Med dette forslag opfordres Rådet og Europa-Parlamentet til at tillade, at yderligere 718 farmaceutiske og kemiske produkter tilføjes på listen over de 8 619 produkter, der opfylder betingelserne for obligatorisk behandling med toldfritagelse ved import til EU.Der blev i 2009 foretaget en fjerde revision af de produkter, der er omfattet af referatet, i overensstemmelse med referatets artikel 3, som kræver, at deltagerne mindst hvert tredje år reviderer produktdækningen med henblik på at tilføje yderligere farmaceutiske produkter, der ikke længere skal belægges med told. EU deltog i disse tekniske drøftelser. I forbindelse med drøftelserne konkluderede deltagerne, at yderligere en række INN og farmaceutiske mellemstoffer, der bruges til produktion og fremstilling af farmaceutiske færdigvarer, bør indrømmes toldfritagelse, og at listen over specificerede præfikser og suffikser for salte, estere eller hydrater af INN bør udvides, hvorved listen over produkter, som opfylder betingelserne for behandling med toldfritagelse, udvides med 718 nye stoffer.Medlemsstaterne er blevet hørt i forbindelse med de tekniske drøftelser.Rådet og Europa-Parlamentet opfordres til at vedtage vedlagte forslag til Europa-Parlamentets og Rådets forordning om ændring af bilag I til Rådets forordning (EØF) nr. 2658/87 for at udvide behandlingen med toldfritagelse i Den Europæiske Union til ovennævnte farmaceutiske og kemiske produkter.2010/0214 (COD)Forslag tilEUROPA-PARLAMENTETS OG RÅDETS FORORDNINGom sikring af toldfri behandling af visse aktive farmaceutiske ingredienser på WHO's liste over internationale ikke-navnebeskyttede navne (INN) og af visse produkter, der anvendes til fremstilling af farmaceutiske færdigvarer, og om ændring af bilag I til forordning (EØF) nr. 2658/87EUROPA-PARLAMENTET OG RÅDET FOR DEN EUROPÆISKE UNION HAR -under henvisning til traktaten om Den Europæiske Unions funktionsmåde, særlig artikel 207,under henvisning til forslag fra Europa-Kommissionen,efter fremsendelse af udkastet til retsakt til de nationale parlamenter,efter den almindelige lovgivningsprocedure ogud fra følgende betragtninger:(1) Under forhandlingerne i Uruguayrunden vedtog Fællesskabet og en række lande, at der bør indrømmes toldfri behandling for farmaceutiske varer henhørende under kapitel 30 i det harmoniserede system (HS) og HS-position 2936, 2937, 2939 og 2941 og for nærmere angivne aktive farmaceutiske ingredienser med internationale ikke-navnebeskyttede navne (INN) fra Verdenssundhedsorganisationen (WHO) samt for nærmere angivne salte, estere og hydrater af sådanne INN og desuden for nærmere angivne farmaceutiske mellemstoffer, der anvendes til produktion og fremstilling af farmaceutiske færdigvarer.(2) Resultaterne af drøftelserne som gengivet i referatet blev indarbejdet i deltagernes toldlister, der er bilagt Marrakeshprotokollen til GATT 1994.(3) Deltagerne konkluderede, at repræsentanterne for de medlemmer af Verdenshandelsorganisationen (WTO), der deltog i drøftelserne, skal mødes inden for rammerne af WTO's Råd for Handel med Varer, sædvanligvis mindst én gang hvert tredje år, for at revidere produktdækningen med henblik på ved konsensus at tilføje yderligere farmaceutiske produkter, der ikke længere skal belægges med told.(4) Tre sådanne revisioner har fundet sted, og resultatet er, at der er indrømmet behandling med toldfritagelse af yderligere et bestemt antal INN og farmaceutiske mellemstoffer, der bruges til produktion og fremstilling af farmaceutiske færdigvarer, at visse af disse mellemstoffer er overført til listen over INN, og at listen over nærmere bestemte præfikser og suffikser for salte, estere eller hydrater af INN er blevet udvidet.(5) En fjerde revision blev skønnet nødvendig og blev iværksat i 2009. Det blev konkluderet, at der bør indrømmes behandling med toldfritagelse af yderligere et bestemt antal INN og farmaceutiske mellemstoffer, der bruges til produktion og fremstilling af farmaceutiske færdigvarer, at et bestemt antal af de allerede tilføjede mellemstoffer bør overføres til listen over INN, og at listen over nærmere bestemte præfikser og suffikser for salte, estere eller hydrater af INN bør udvides.(6) Ved Rådets forordning (EØF) nr. 2658/87 af 23. juli 1987 om told- og statistiknomenklaturen og den fælles toldtarif[1] indføres den kombinerede nomenklatur (KN) og fastsættes den fælles toldtarifs konventionelle toldsatser.(7) Forordning (EØF) nr. 2658/87 bør ændres i overensstemmelse hermed.(8) (For at sikre, at de i denne forordning fastsatte foranstaltninger anvendes den 1. januar 2011, bør denne forordning træde i kraft på dagen efter offentliggørelsen -].VEDTAGET DENNE FORORDNING:Artikel 1Fra den 1. januar 2011 indrømmer Den Europæiske Union toldfritagelse for de i bilag I angivne INN.Artikel 2Listen over præfikser og suffikser, som i forbindelse med de anførte INN beskriver de salte, estere eller hydrater af INN, som også er berettigede til behandling med toldfritagelse, under forudsætning af at disse kan tariferes i samme 6-cifrede HS-underposition som det tilsvarende INN, ændres fra den 1. januar 2011 som anført i bilag II.Artikel 3Fra den 1. januar 2011 indrømmer Unionen toldfritagelse for de farmaceutiske mellemstoffer, der anvendes til produktion og fremstilling af de farmaceutiske færdigvarer, der er opført i bilag III.Artikel 4Fra den 1. januar 2011 skal de farmaceutiske mellemstoffer, der er opført i bilag IV, slettes på listen over de stoffer, som er fritaget for told.Artikel 5Bilag 3, 4 og 6 i III. del, afsnit II, i bilag I til forordning (EØF) nr. 2658/87 (Liste over farmaceutiske stoffer, som opfylder betingelserne for behandling med toldfritagelse) ændres i overensstemmelse hermed.Artikel 6Denne forordning træder i kraft dagen efter offentliggørelsen i Den Europæiske Unions Tidende .Denne forordning er bindende i alle enkeltheder og gælder umiddelbart i hver medlemsstat.Udfærdiget i Bruxelles, den […].På Europa-Parlamentets vegne På Rådets vegne[…] […] Formand FormandBILAG IListe over internationale ikke-navnebeskyttede navne (INN), der skal tilføjes på listen over produkter, der er fritaget for told, i bilag 3 til bilag I til forordning (EØF) nr. 2658/87KN-kode | CAS RN | Betegnelse |2842 90 80 | 119175-48-3 | fermagat |2843 90 90 | 759457-82-4 | padeliporfin |2844 40 30 | 123748-56-1 | iodfiltinsyre (123I) |2904 10 00 | 21668-77-9 | eprodisat |2906 19 00 | 199798-84-0 | elocalcitol |2909 30 90 | 24150-24-1 | terameprocol |2916 19 95 | 81485-25-8 | peretinoin |2916 39 00 | 51543-40-9 | tarenflurbil |2918 19 98 | 174022-42-5 | bevirimat |2919 90 00 | 258516-89-1 | fospropofol |2920 90 85 | 163133-43-5 | naproxcinod |2921 19 99 | 3687-18-1 | tramiprosat |2922 19 85 | 68392-35-8 | afimoxifen |2922 19 85 | 753449-67-1 | ronacaleret |2922 29 00 | 433265-65-7 | faxeladol |2922 50 00 | 121524-08-1 | amibegron |2922 50 00 | 329773-35-5 | cinaciguat |2922 50 00 | 643094-49-9 | fasobegron |2923 10 00 | 856676-23-8 | cholinfenofibrat |2924 29 98 | 847353-30-4 | arbaclofenplacarbil |2924 29 98 | 194785-19-8 | bedoradrin |2924 29 98 | 194085-75-1 | carisbamat |2924 29 98 | 254750-02-2 | emricasan |2924 29 98 | 355129-15-6 | eprotirom |2924 29 98 | 402567-16-2 | firategrast |2924 29 98 | 478296-72-9 | gabapentinenacarbil |2924 29 98 | 15866-90-7 | incyclinid |2924 29 98 | 202844-10-8 | indantadol |2924 29 98 | 96847-55-1 | levomilnacipran |2924 29 98 | 608137-32-2 | lisdexamfetamin |2924 29 98 | 652990-07-3 | milveterol |2924 29 98 | 181816-48-8 | ombrabulin |2924 29 98 | 289656-45-7 | senicapoc |2925 19 95 | 19171-19-8 | pomalidomid |2928 00 90 | 22033-87-0 | olesoxim |2928 00 90 | 2675-35-6 | sivifen |2928 00 90 | 816458-31-8 | tecovirimat |2928 00 90 | 238750-77-1 | tosedostat |2928 00 90 | 149647-78-9 | vorinostat |2929 90 00 | 31645-39-3 | palifosfamid |2930 90 99 | 608141-41-9 | apremilast |2930 90 99 | 216167-92-9 | camobucol |2930 90 99 | 211513-37-0 | dalcetrapib |2930 90 99 | 69819-86-9 | darinaparsin |2930 90 99 | 488832-69-5 | elesclomol |2930 90 99 | 216167-95-2 | elsibucol |2930 90 99 | 168682-53-9 | ezatiostat |2930 90 99 | 58569-55-4 | metenkefalin |2930 90 99 | 887148-69-8 | monepantel |2930 90 99 | 603139-19-1 | odanacatib |2930 90 99 | 162520-00-5 | salirasib |2930 90 99 | 216167-82-7 | succinobucol |2930 90 99 | 125961-82-2 | tipelukast |2931 00 99 | 125973-56-0 | amsilaroten |2932 19 00 | 253128-41-5 | eribulin |2932 19 00 | 186953-56-0 | pafuramidin |2932 29 85 | 195883-06-8 | omtriptolid |2932 99 00 | 664338-39-0 | arterolan |2932 99 00 | 183133-96-2 | cabazitaxel |2932 99 00 | 401925-43-7 | celivaron |2932 99 00 | 461432-26-8 | dapagliflozin |2932 99 00 | 118457-15-1 | dexnebivolol |2932 99 00 | 156294-36-9 | larotaxel |2932 99 00 | 118457-16-2 | levonebivolol |2932 99 00 | 83461-56-7 | mifamurtid |2932 99 00 | 117570-53-3 | vadimezan |2933 19 90 | 496775-61-2 | eltrombopag |2933 19 90 | 206884-98-2 | niraxostat |2933 19 90 | 410528-02-8 | palovaroten |2933 19 90 | 376592-42-6 | totrombopag |2933 29 90 | 183659-72-5 | catramilast |2933 29 90 | 944263-65-4 | demiditraz |2933 29 90 | 867153-61-5 | dulanermin |2933 29 90 | 320367-13-3 | lixisenatid |2933 29 90 | 698389-00-3 | rolipoltid |2933 29 90 | 697766-75-9 | velafermin |2933 39 99 | 147084-10-4 | alcaftadin |2933 39 99 | 54-96-6 | amifampridin |2933 39 99 | 249921-19-5 | anamorelin |2933 39 99 | 319460-85-0 | axitinib |2933 39 99 | 208110-64-9 | befiradol |2933 39 99 | 330942-05-7 | betrixaban |2933 39 99 | 201034-75-5 | daporinad |2933 39 99 | 209783-80-2 | entinostat |2933 39 99 | 412950-27-7 | goxalapladib |2933 39 99 | 218791-21-0 | imisopasemmangan |2933 39 99 | 103129-82-4 | levamlodipin |2933 39 99 | 154357-42-3 | levonadifloxacin |2933 39 99 | 108147-54-2 | migalastat |2933 39 99 | 453562-69-1 | motesanib |2933 39 99 | 139145-27-0 | parogrelil |2933 39 99 | 459856-18-9 | pexacerfont |2933 39 99 | 706779-91-1 | pimavanserin |2933 39 99 | 362665-56-3 | pitolisant |2933 39 99 | 861151-12-4 | rosonabant |2933 39 99 | 701977-09-5 | taranabant |2933 39 99 | 189950-11-6 | tropantiol |2933 39 99 | 793655-64-8 | vapitadin |2933 39 99 | 139290-65-6 | volinaserin |2933 49 90 | 141388-76-3 | besifloxacin |2933 49 90 | 697761-98-1 | elvitegravir |2933 49 90 | 185055-67-8 | ferroquin |2933 49 90 | 445041-75-8 | intiquinatin |2933 49 90 | 378746-64-6 | nemonoxacin |2933 49 90 | 245765-41-7 | ozenoxacin |2933 49 90 | 412950-08-4 | rilapladib |2933 49 90 | 871224-64-5 | almorexant |2933 49 90 | 863029-99-6 | balamapimod |2933 49 90 | 698387-09-6 | neratinib |2933 49 90 | 154652-83-2 | tezampanel |2933 49 90 | 128253-31-6 | veliflapon |2933 59 95 | 791828-58-5 | aderbasib |2933 59 95 | 840486-93-3 | adipiplon |2933 59 95 | 850649-61-5 | alogliptin |2933 59 95 | 859212-16-1 | bafetinib |2933 59 95 | 380843-75-4 | bosutinib |2933 59 95 | 839712-12-8 | cariprazin |2933 59 95 | 414910-27-3 | casopitant |2933 59 95 | 288383-20-0 | cediranib |2933 59 95 | 849550-05-6 | cevipabulin |2933 59 95 | 827318-97-8 | danusertib |2933 59 95 | 356057-34-6 | darapladib |2933 59 95 | 501000-36-8 | dutacatib |2933 59 95 | 247257-48-3 | fimasartan |2933 59 95 | 3432-99-3 | folitixorin |2933 59 95 | 668270-12-0 | linagliptin |2933 59 95 | 441798-33-0 | macitentan |2933 59 95 | 641571-10-0 | nilotinib |2933 59 95 | 763113-22-0 | olaparib |2933 59 95 | 686344-29-6 | otenabant |2933 59 95 | 625115-55-1 | riociguat |2933 59 95 | 486460-32-6 | sitagliptin |2933 59 95 | 425637-18-9 | sotrastaurin |2933 59 95 | 309913-83-5 | talmapimod |2933 59 95 | 113857-87-7 | talotrexin |2933 59 95 | 274693-27-5 | ticagrelor |2933 59 95 | 306296-47-9 | vicriviroc |2933 69 80 | 775351-65-0 | imeglimin |2933 79 00 | 461443-59-4 | aplaviroc |2933 79 00 | 189691-06-3 | bremelanotid |2933 79 00 | 813452-18-5 | carmegliptin |2933 79 00 | 405169-16-6 | dovitinib |2933 79 00 | 536748-46-6 | eribaxaban |2933 79 00 | 473289-62-2 | ilepatril |2933 79 00 | 180694-97-7 | mimopezil |2933 79 00 | 579475-18-6 | orvepitant |2933 79 00 | 449811-01-2 | pamapimod |2933 79 00 | 248282-01-1 | paquinimod |2933 79 00 | 380917-97-5 | perampanel |2933 79 00 | 552292-08-7 | rolapitant |2933 79 00 | 425386-60-3 | semagacestat |2933 79 00 | 515814-01-4 | voclosporin |2933 99 80 | 481629-87-2 | aleplasinin |2933 99 80 | 394730-60-0 | boceprevir |2933 99 80 | 649735-63-7 | brivanibalaninat |2933 99 80 | 483369-58-0 | denagliptin |2933 99 80 | 284019-34-7 | denibulin |2933 99 80 | 481631-45-2 | diaplasinin |2933 99 80 | 272105-42-7 | disitertid |2933 99 80 | 227318-71-0 | epetirimod |2933 99 80 | 259793-96-9 | favipiravir |2933 99 80 | 871576-03-3 | flovagatran |2933 99 80 | 229305-39-9 | golotimod |2933 99 80 | 258818-34-7 | larazotid |2933 99 80 | 571170-77-9 | laropiprant |2933 99 80 | 616202-92-7 | lorcaserin |2933 99 80 | 868771-57-7 | melogliptin |2933 99 80 | 803712-67-6 | obatoclax |2933 99 80 | 404950-80-7 | panobinostat |2933 99 80 | 625114-41-2 | piragliatin |2933 99 80 | 74847-35-1 | pyronaridin |2933 99 80 | 872178-65-9 | rabeximod |2933 99 80 | 355151-12-1 | rotigaptid |2933 99 80 | 497221-38-2 | rusalatid |2933 99 80 | 187602-11-5 | sofigatran |2933 99 80 | 227318-75-4 | sotirimod |2933 99 80 | 402957-28-2 | telaprevir |2933 99 80 | 848084-83-3 | tigapotid |2933 99 80 | 393105-53-8 | tiplasinin |2933 99 80 | 620948-93-8 | vabicaserin |2933 99 80 | 794466-70-9 | vernakalant |2934 10 00 | 544417-40-5 | capadenoson |2934 10 00 | 302962-49-8 | dasatinib |2934 10 00 | 223132-37-4 | inolitazon |2934 10 00 | 241479-67-4 | isavuconazol |2934 10 00 | 338990-84-4 | isavuconazoniumchlorid |2934 10 00 | 607723-33-1 | lobeglitazon |2934 10 00 | 280782-97-0 | managlinatdialanetil |2934 10 00 | 790299-79-5 | masitinib |2934 10 00 | 223673-61-8 | mirabegron |2934 10 00 | 501948-05-6 | rosabulin |2934 10 00 | 447406-78-2 | sodelglitazar |2934 10 00 | 760937-92-6 | teneligliptin |2934 20 80 | 848344-36-5 | bentamapimod |2934 20 80 | 870093-23-5 | talarozol |2934 99 90 | 320345-99-1 | aclidiniumbromid |2934 99 90 | 222551-17-9 | adoprazin |2934 99 90 | 207623-20-9 | agatolimod |2934 99 90 | 475479-34-6 | aleglitazar |2934 99 90 | 870524-46-2 | amolimogenbepiplasmid |2934 99 90 | 875446-37-0 | anacetrapib |2934 99 90 | 250386-15-3 | apadenoson |2934 99 90 | 541550-19-0 | apilimod |2934 99 90 | 160707-69-7 | apricitabin |2934 99 90 | 147403-03-0 | azilsartan |2934 99 90 | 863031-21-4 | azilsartanmedoxomil |2934 99 90 | 757942-43-1 | bederocin |2934 99 90 | 627861-07-8 | beperminogenperplasmid |2934 99 90 | 959961-96-7 | bevasiranib |2934 99 90 | 769901-96-4 | capeserod |2934 99 90 | 868540-17-4 | carfilzomib |2934 99 90 | 872847-66-0 | cenersen |2934 99 90 | 80295-38-1 | conestat alfa |2934 99 90 | 903916-27-8 | custirsen |2934 99 90 | 187865-22-1 | derquantel |2934 99 90 | 134379-77-4 | dexelvucitabin |2934 99 90 | 247046-52-2 | dilopetin |2934 99 90 | 480449-70-5 | edoxaban |2934 99 90 | 188181-42-2 | elacytarabin |2934 99 90 | 98819-76-2 | esreboxetin |2934 99 90 | 763903-67-9 | fosalvudintidoxil |2934 99 90 | 172673-20-0 | fosaprepitant |2934 99 90 | 522664-63-7 | ibodutant |2934 99 90 | 405159-59-3 | idrabiotaparinuxnatrium |2934 99 90 | 188116-07-6 | imepitoin |2934 99 90 | 335619-18-6 | inakalant |2934 99 90 | 1391-36-2 | lancovutid |2934 99 90 | 189059-71-0 | lapaquistat |2934 99 90 | 327026-93-7 | lensiprazin |2934 99 90 | 170632-47-0 | lificiguat |2934 99 90 | 852313-25-8 | litenimod |2934 99 90 | 1000120-98-8 | mipomersen |2934 99 90 | 62253-63-8 | nepidermin |2934 99 90 | 26833-87-4 | omacetaxinmepesuccinat |2934 99 90 | 269718-84-5 | pardoprunox |2934 99 90 | 219923-85-0 | pramiconazol |2934 99 90 | 377727-87-2 | preladenant |2934 99 90 | 524684-52-4 | prinaberel |2934 99 90 | 865311-47-3 | quarfloxin |2934 99 90 | 869884-78-6 | radezolid |2934 99 90 | 496054-87-6 | radiprodil |2934 99 90 | 518048-05-0 | raltegravir |2934 99 90 | 787548-03-2 | regrelor |2934 99 90 | 820957-38-8 | retosiban |2934 99 90 | 572924-54-0 | ridaforolimus |2934 99 90 | 128517-07-7 | romidepsin |2934 99 90 | 93265-81-7 | ropidoxuridin |2934 99 90 | 151823-14-2 | sapacitabin |2934 99 90 | 379231-04-6 | saracatinib |2934 99 90 | 791635-59-1 | simotaxel |2934 99 90 | 119567-79-2 | taribavirin |2934 99 90 | 332012-40-5 | telatinib |2934 99 90 | 925681-61-4 | trabedersen |2934 99 90 | 189003-92-7 | trelanserin |2934 99 90 | 296251-72-4 | velimogenaliplasmid |2934 99 90 | 904302-98-3 | viquidacin |2934 99 90 | 872525-61-6 | votucalis |2934 99 90 | 221877-54-9 | zotarolimus |2935 00 90 | 197904-84-0 | apricoxib |2935 00 90 | 769169-27-9 | begacestat |2935 00 90 | 414864-00-9 | belinostat |2935 00 90 | 313682-08-5 | brecanavir |2935 00 90 | 839673-52-8 | cevoglitazar |2935 00 90 | 358970-97-5 | drinabant |2935 00 90 | 865200-20-0 | giripladib |2935 00 90 | 464213-10-3 | ibipinabant |2935 00 90 | 173424-77-6 | laromustin |2935 00 90 | 398507-55-6 | lodenafilcarbonat |2935 00 90 | 136564-68-6 | masilukast |2935 00 90 | 170569-88-7 | mavacoxib |2935 00 90 | 862189-95-5 | mirodenafil |2935 00 90 | 439687-69-1 | nelivaptan |2935 00 90 | 691852-58-1 | nesbuvir |2935 00 90 | 778576-62-8 | oglemilast |2935 00 90 | 444731-52-6 | pazopanib |2935 00 90 | 362505-84-8 | relacatib |2935 00 90 | 243984-11-4 | resatorvid |2935 00 90 | 519055-62-0 | tasisulam |2935 00 90 | 186497-07-4 | zibotentan |2936 29 00 | 104121-92-8 | eldecalcitol |2936 29 00 | 31690-09-2 | levomefolinsyre |2937 19 00 | 782500-75-8 | albiglutid |2937 19 00 | 348119-84-6 | obinepitid |2937 19 00 | 295350-45-7 | ozarelix |2937 19 00 | 275371-94-3 | taspoglutid |2937 19 00 | 218949-48-5 | tesamorelin |2937 19 00 | 22006-64-0 | tridecactid |2937 22 00 | 132245-57-9 | dexamethasoncipecilat |2937 22 00 | 397864-44-7 | fluticasonfuroat |2937 29 00 | 211254-73-8 | lonaprisan |2937 50 00 | 333963-42-1 | cobiproston |2937 50 00 | 172740-14-6 | posaraprost |2937 90 00 | 834153-87-6 | elagolix |2937 90 00 | 609799-22-6 | tasimelteon |2937 90 00 | 342577-38-2 | velneperit |2939 19 00 | 73232-52-7 | methylnaltrexonbromid |2939 59 00 | 136199-02-5 | rolofyllin |2939 99 00 | 850607-58-8 | darotropiumbromid |2939 99 00 | 187852-63-7 | delimotecan |2940 00 00 | 9007-72-1 | ferricarboxymaltose |2940 00 00 | 442201-24-3 | remogliflozinetabonat |2940 00 00 | 408504-26-7 | sergliflozinetabonat |2941 90 00 | 467214-20-6 | alvespimycin |2941 90 00 | 677017-23-1 | berubicin |2941 90 00 | 229016-73-3 | ceftarolinfosamil |2941 90 00 | 318498-76-9 | flopristin |2941 90 00 | 145435-72-9 | gamithromycin |2941 90 00 | 325965-23-9 | linopristin |2941 90 00 | 857402-23-4 | retaspimycin |2941 90 00 | 305841-29-6 | sagopilon |2941 90 00 | 75747-14-7 | tanespimycin |2941 90 00 | 328898-40-4 | tildipirosin |2941 90 00 | 222400-20-6 | tomopenem |2941 90 00 | 63409-12-1 | tylvalosin |3001 90 91 | 9041-08-1 | semuloparinnatrium |3002 10 91 | 792921-10-9 | abagovomab |3002 10 91 | 910649-32-0 | anrukinzumab |3002 10 91 | 648904-28-3 | bavituximab |3002 10 91 | 402710-27-4 (let kæde) 402710-25-2 (tung kæde) | canakinumab |3002 10 99 | 945228-49-9 | citatuzumabbogatox |3002 10 91 | 880486-59-9 | dacetuzumab |3002 10 91 | 615258-40-7 | denosumab |3002 10 91 | 762260-74-2 | efungumab |3002 10 91 | 89957-37-9 | gantenerumab |3002 10 91 | 680188-33-4 | ibalizumab |3002 10 91 | 477202-00-9 | ipilimumab |3002 10 91 | 640735-09-7 | iratumumab |3002 10 91 | 845816-02-6 | lexatumumab |3002 10 91 | 903512-50-5 | lucatumumab |3002 10 91 | 899796-83-9 | milatuzumab |3002 10 91 | 677010-34-3 | motavizumab |3002 10 91 | 676258-98-3 | naptumomabestafenatox |3002 10 91 | 828933-51-3 | nimotuzumab |3002 10 91 | 949142-50-1 | obinutuzumab |3002 10 91 | 637334-45-3 | ocrelizumab |3002 10 91 | 881191-44-2 | otelixizumab |3002 10 91 | 372075-37-1 | sontuzumab |3002 10 91 | 705287-60-1 | stamulumab |3002 10 91 | 339086-80-5 | tadocizumab |3002 10 91 | 592557-43-2 (let kæde) 592557-41-0 (tung kæde) | tenatumomab |3002 10 91 | 876387-05-2 | teplizumab |3002 10 91 | 918127-53-4 | tigatuzumab |3002 10 91 | 745013-59-6 | tremelimumab |3002 10 91 | 339986-90-2 | tucotuzumabcelmoleukin |3002 10 91 | 728917-18-8 | veltuzumab |3002 10 91 | 896731-82-1 | conatumumab |3002 10 91 | 892553-42-3 | etaracizumab |3002 10 91 | 944548-38-3 | foravirumab |3002 10 91 | 944548-37-2 | rafivirumab |3002 10 91 | 880266-57-9 | tanezumab |3002 10 91 | 815610-63-0 | ustekinumab |3002 10 95 | 862111-32-8 | aflibercept |3002 10 95 | 845264-92-8 | atacicept |3002 10 95 | 909110-25-4 | baminercept |3002 10 95 | 9001-27-8 | beroctocog alfa |3002 10 95 | 879555-13-2 | epoetin kappa |3002 10 95 | 762263-14-9 | epoetin theta |3002 10 95 | 501081-76-1 | rilonacept |3002 10 95 | 267639-76-9 | romiplostim |3002 10 95 | 869858-13-9 | thrombin alfa |3002 10 95 | 897936-89-9 | vatreptacog alfa (aktiveret) |3002 10 95 | 472960-22-8 | albinterferon alfa-2b |3002 10 95 | 869881-54-9 | briobacept |3002 10 95 | 606138-08-3 | catridecacog |3002 10 95 | 716840-32-3 | denenicokin |3002 10 95 | 931101-84-7 | troplasminogen alfa |3002 10 99 | 934216-54-3 | alacizumabpegol |3002 20 00 | 181477-43-0 | disomotid |3002 20 00 | 181477-91-8 | ovemotid |3002 20 00 | 915019-08-8 | tertomotid |3002 20 00 | 295371-00-5 | verpasepcaltespen |3002 90 90 | 473553-86-5 | alferminogentadenovec |3002 90 90 | 929881-05-0 | alipogentiparvovec |3002 90 90 | 600735-73-7 | contusugenladenovec |3002 90 90 | 851199-59-2 | linaclotid |3002 90 90 | 898830-54-1 | sitimagenceradenovec |3002 90 90 | 721946-42-5 | transferrinaldifitox |3507 90 90 | 9026-00-0 | bucelipase alfa |3507 90 90 | 885051-90-1 | pegloticase |3507 90 90 | 884604-91-5 | velaglucerase alfa |3911 90 99 | 892497-01-7 | azoximerbromid |BILAG IIListe over præfikser og suffikser, som i forbindelse med de i bilag 3 til bilag I til forordning (EØF) nr. 2658/87 nævnte INN beskriver salte, estere eller hydrater af INN; disse salte, estere og hydrater er fritaget for told, forudsat at de kan tariferes i samme 6-cifrede HS-underposition som det tilsvarende INNHenvisningerne til "International Nonproprietary Names (INN) for pharmaceutical substances, Names for radicals & groups, comprehensive list 2004" erstattes af henvisninger til "International Nonproprietary Names (INN) for pharmaceutical substances, Names for radicals, groups & others, comprehensive list 2007".Følgende præfikser eller suffikser tilføjes:Foretrukket præfiks eller suffiks | Synonymer | Systematisk navn (i tilfælde af forskel) |alanetil (INNRG) | [(S)-1-ethoxy-1-oxo-propan-2-yl]amino (INNCN) |alaninat (INNRG) | L-alaninat (INNCN) |alapivoxil (INNRG) | L-alanyl, [(2,2-dimethylpropanoyl)oxy]methyl (INNCN) |aldifitox (INNRG) | (4-iminobutan-1,4-diyl)sulfandiyl[(3RS)-2,5-dioxopyrrolidin-1,3-diyl]-1,3-phenylencarbonyl, som danner et N-benzoylderivat med en gruppe af primære aminer af difteri-[550-L-phenylalanin]toksin fra Corynebacterium diphtheriae-(26-560)-peptid (INNCN) |besudotox (INNRG) | L-lysyl-L-alanyl-L-serylglycylglycin (linker) fusionsprotein med des-(365-380)-[Asn364,Val407,Ser515,Gln590,Gln606,Arg613]exotoksin A (Pseudomonas aeruginosa)-(251-613)-peptid (toksin, hvor region IA og de første 16 rester af region IB er deleteret) (INNCN) |ceribat (INNRG) | rac-2,3-dihydroxypropylcarbonat (ester) (INNCN) |cipecilat (INNRG) | cyclohexancarboxylat (ester), cyclopropancarboxylat (ester) (INNCN) |dalanated (INNRG) | des-B30-alanin (INNCN) |enacarbil (INNRG) | {rac-1-[(2-methylpropanoyl)oxy]ethoxy}carbonyl (INNCN) |estafenatox (INNRG) | glycylglycyl-L-prolin (linker) fusionsprotein med enterotoksin type A (Staphylococcus aureus)-(1-33)-peptidyl-L-seryl[Ser36,Ser37,Glu38,Lys39,Ala41,Thr46,Thr71,Ala72,Ser75,Glu76,Glu78,Ser80,Ser81,Thr214,Ser217,Thr219,Ser220,Ser222,Ser224]enterotoksin type E (Staphylococcus aureus)-(32-230)-peptid (syntetisk superantigen SEA/E-120) (INNCN) |etexilat (INNRG) | ethyl, (hexyloxy)carbonyl |fosamil (INNRG) | phosphono (INNCN) |glucuronid (INNRG) | β-D-glucopyranosiduronsyre [osid] (INNCN) |medocaril (INNRG) | [(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl (INNCN) |paptox (INNRG) | protein PAP (Phytolacca americana antiviral) (INNCN) |placarbil (INNRG) | (R)-2-methyl-1-[(2-methylpropanoyl)oxy]propoxy}carbonyl) (INNCN) |De systematiske navne af følgende præfikser eller suffikser ændres således:Foretrukket præfiks eller suffiks | Synonymer | Systematisk navn (i tilfælde af forskel) |aritox (INNRG) | ricins A-kæde (INNCN) |BILAG IIIListe over farmaceutiske mellemstoffer, dvs. stoffer der bruges til fremstilling af farmaceutiske færdigvarer, der skal tilføjes til listen over produkter, der er fritaget for told, i bilag 6 til bilag I til forordning (EØF) nr. 2658/87ID | KN-kode | CAS RN | Betegnelse |95 | 2843 29 00 | 22199-08-2 | [4-amino-N-(pyrimidin-2(1H)-yliden-κN1)benzensulfonamidato-κO]sølv |428 | 2905 39 95 | 281214-27-5 | (2R,3R)-2,3-dimethylbutan-1,4-diylbis(4-methylbenzensulfonat) |76 | 2905 59 98 | 441002-17-1 | 4-chlorbutyl-2-nitrobenzensulfonat |538 | 2909 30 90 | 92878-95-0 | 2-(3-chlorpropoxy)-1-methoxy-4-nitrobenzen |168 | 2909 30 | 503070-57-3 | 2-({2-[(6-bromhexyl)oxy]ethoxy}methyl)-1,3-dichlorbenzen |386 | 2909 30 | 461432-23-5 | 4-(5-brom-2-chlorbenzyl)phenylethylether |51 | 2909 49 80 | 185954-75-0 | (3R)-3-methoxydecan-1-ol |167 | 2909 49 80 | 85309-91-7 | 2-[(2,6-dichlorbenzyl)oxy]ethanol |64 | 2909 49 80 | 160969-03-9 | 2-[2-(2,2,2-trifluorethoxy)phenoxy]ethylmethansulfonat |98 | 2909 50 00 | 167145-13-3 | 2-[2-(3-methoxyphenyl)ethyl]phenol |377 | 2910 20 00 | 15448-47-2 | (2R)-2-methyloxiran |177 | 2910 90 00 | 62600-71-9 | (2R)-2-(3-chlorphenyl)oxiran |184 | 2910 90 00 | 702687-42-1 | (2R)-2-[(5-brom-2,3-difluorphenoxy)methyl]oxiran |88 | 2910 90 00 | 683276-64-4 | [(2R)-2-methyloxiran-2-yl]methyl 4-nitrobenzensulfonat |191 | 2913 00 00 | 90035-34-0 | 4'-(trifluormethyl)biphenyl-4-carbaldehyd |38 | 2914 40 90 | 17752-16-8 | (3β)-3-hydroxycholest-5-en-24-on |244 | 2914 50 00 | 974-23-2 | (3β,16α)-3-hydroxy-16,17-epoxypregn-5-en-20-on |586 | 2914 70 00 | 13054-81-4 | 4-chlor-heptan-3,5-dion |236 | 2914 70 00 | 10226-30-9 | 6-chlorhexan-2-on |122 | 2915 60 90 | 53064-79-2 | iodmethylpivalat |426 | 2915 90 00 | 22328-90-1 | (3R)-3-methylhexansyre |266 | 2915 90 00 | 1069-66-5 | natrium-2-propylpentanoat |19 | 2916 20 00 | 211515-46-7 | 1-(2-ethylbutyl)cyclohexancarbonylchlorid |32 | 2916 20 00 | 381209-09-2 | 1-(2-ethylbutyl)cyclohexancarboxylsyre |37 | 2916 20 00 | 7077-05-6 | trans-4-(propan-2-yl)cyclohexancarboxylsyre |531 | 2916 39 00 | 21900-39-0 | 5-fluor-2-methylbenzoylchlorid |250 | 2916 39 00 | 17625-03-5 | natriumhydrogen-3-sulfonatobenzoat |561 | 2917 19 90 | 76-72-2 | diethylethyl(pentan-2-yl)propandioat |193 | 2918 29 00 | 376592-58-4 | 5'-chlor-2'-hydroxy-3'-nitrobiphenyl-3-carboxylsyre |369 | 2918 99 90 | 709031-28-7 | (3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)(oxo)eddikesyre |552 | 2918 99 90 | 35480-52-5 | 2,5-bis(2,2,2-trifluorethoxy)benzoesyre |559 | 2918 99 90 | 4651-67-6 | (3α,5β)-3-hydroxy-7-oxocholan-24-syre |264 | 2918 99 90 | 52179-28-9 | ethyl-2-[4-(2,2-dichlorcyclopropyl)phenoxy]-2-methylpropanoat |143 | 2918 99 90 | 530141-60-7 | methyl-3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-hydroxyphenyl)propanoat |114 | 2920 90 10 | 91526-18-0 | 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-on |161 | 2921 49 00 | 334477-60-0 | (1R)-1-[3,5-bis(trifluormethyl)phenyl]-N-methylethanamin |287 | 2921 49 00 | 376608-71-8 | (1R,2S)-2-(3,4-difluorphenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoat |342 | 2921 49 00 | 1034457-07-2 | 2-(2,3-dihydro-1H-inden-2-yl)propan-2-aminhydrochlorid |27 | 2921 49 00 | 945717-05-5 | 2-(4-chlor-3-ethylphenyl)ethanaminhydrochlorid |221 | 2921 49 00 | 89-97-4 | 2-chlorbenzylamin |26 | 2921 49 00 | 945717-43-1 | N-(4-tert-butylbenzyl)-2-(4-chlor-3-ethylphenyl)ethanamin |518 | 2921 51 90 | 150812-21-8 | N4-[(4-fluorphenyl)methyl]-2-nitro-1,4-benzendiamin |343 | 2922 19 80 | 1035455-90-3 | (2R)-1-(5-brom-2,3-difluorphenoxy)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2- yl]amino}propan-2-ol hydrochlorid |397 | 2922 19 80 | 0-00-0 | [2-(chlormethyl)-4-(dibenzylamino)phenyl]methanolhydrochlorid |248 | 2922 19 80 | 133-51-7 | antimonsyre -- 1-deoxy-1-(methylamino)-D-glucitol (1:1) |344 | 2922 19 80 | 1035455-87-8 | ethyl-(2E)-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorphenyl)prop-2-enoathydrochlorid |185 | 2922 19 80 | 702686-97-3 | ethyl-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorphenyl)propanoathydrochlorid |36 | 2922 29 00 | 20059-73-8 | 2-[4-(aminomethyl)phenoxy]-N,N-dimethylethanamin |536 | 2922 49 85 | 848133-35-7 | (2E)-4-(dimethylamino)but-2-ensyrehydrochlorid |425 | 2922 49 85 | 610300-07-7 | (3S,5R)-3-amino-5-methyloctansyre |424 | 2922 49 85 | 610300-00-0 | (3S,5R)-3-amino-5-methyloctansyrehydrochlorid |433 | 2922 49 85 | 143785-86-8 | 4-(1-aminocyclopropyl)-2,3,5-trifluorbenzoesyre |398 | 2922 49 85 | 848949-85-9 | 4-fluor-L-leucin -- ethylhydrogensulfat (1:1) |475 | 2922 49 85 | 39068-93-4 | methyl-2-(dimethylamino)-2-phenylbutanoat |174 | 2922 49 85 | 168619-25-8 | methyl-3'-aminobiphenyl-3-carboxylat |565 | 2922 49 85 | 82834-12-6 | N-[(2S)-1-ethoxy-1-oxopentan-2-yl]-L-alanin |474 | 2922 49 85 | 94133-84-3 | natirum-2-amino-2-phenylbutanoat |171 | 2922 50 00 | 503070-58-4 | triphenyleddikesyre -- 4-{(1R)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol (1:1) |149 | 2924 19 00 | 62009-47-6 | 2-aminomalonamid |175 | 2924 19 00 | 7355-58-0 | N-(2-chlorethyl)acetamid |367 | 2924 29 98 | 361442-00-4 | {2-[(tert-butoxycarbonyl)amino]-3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl}eddikesyre |521 | 2924 29 98 | 266993-72-0 | 2,3-diaminobenzamiddihydrochlorid |532 | 2924 29 98 | 168080-49-7 | 2-chlor-4-{[(5-fluor-2-methylphenyl)carbonyl]amino}benzoesyre |81 | 2924 29 98 | 317374-08-6 | 2-methyl-4-{[(2-methylphenyl)carbonyl]amino}benzoesyre |125 | 2924 29 98 | 143785-84-6 | 4-(1-carbamoylcyclopropyl)-2,3,5-trifluorbenzoesyre |434 | 2924 29 98 | 143785-87-9 | 4-[1-(acetylamino)cyclopropyl]-2,3,5-trifluorbenzoesyre |80 | 2924 29 98 | 108166-22-9 | 4-{[(2-methylphenyl)carbonyl]amino}benzoesyre |519 | 2924 29 98 | 150812-23-0 | ethyl-{4-[(4-fluorbenzyl)amino]-2-nitrophenyl}carbamat |237 | 2924 29 98 | 22316-45-6 | ethyl-3-[(5-chlor-2-nitrophenyl)(phenyl)amino]-3-oxopropanoat |3 | 2924 29 98 | 316173-29-2 | methyl-(1S,2S,3S,4R)-3-[(1S)-1-amino-2-ethylbutyl]-4-[(tert-butoxycarbonyl)amino]-2-hydroxycyclopentancarboxylat |378 | 2924 29 98 | 1142-20-7 | N-benzyloxycarbonyl-L-alanin |102 | 2924 29 98 | 84996-93-0 | N-cyclohexyl-5-hydroxypentanamid |270 | 2924 29 98 | 579494-66-9 | propyl-{4-[2-(diethylamino)-2-oxoethoxy]-3-ethoxyphenyl}acetat |533 | 2925 19 95 | 265136-65-0 | ethyl-3-amino-4-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]but-2-enoat |33 | 2926 90 95 | 855425-38-6 | 1-(2-ethylbutyl)cyclohexancarbonitril |537 | 2926 90 95 | 846023-24-3 | 2-cyan-N-(2,4-dichlor-5-methoxyphenyl)acetamid |417 | 2926 90 95 | 591769-05-0 | 3-cyclopentylprop-2-enenitril |50 | 2926 90 95 | 20099-89-2 | 4-(bromacetyl)benzonitril |54 | 2926 90 95 | 474554-45-5 | 4,5-diethoxy-3-fluorbenzen-1,2-dicarbonitril |587 | 2926 90 95 | 79370-78-8 | 5-hydroxybenzen-1,3-dicarbonitril |118 | 2926 90 95 | 139481-28-0 | methyl-2-{[(2'-cyanbiphenyl-4-yl)methyl]amino}-3-nitrobenzoat |182 | 2928 00 90 | 860035-10-5 | 1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl-2-methylpropanoat |403 | 2928 00 90 | 910656-45-0 | 2-hydroxy-2-(trifluormethyl)butanhydrazid |104 | 2928 00 90 | 95759-10-7 | 4-chlor-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutansyre |383 | 2928 00 90 | 473927-63-8 | ethyl-(2Z)-chlor[2-(4-methoxyphenyl)hydrazinyliden]ethanoat |144 | 2928 00 90 | 158671-29-5 | N,2-dihydroxy-4-methylbenzamid |106 | 2928 00 90 | 84080-68-2 | tert-butyl-(2Z)-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoat |105 | 2928 00 90 | 268544-50-9 | tert-butyl-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoat |101 | 2930 90 85 | 13459-62-6 | {2-[(4-chlorphenyl)sulfanyl]phenyl}eddikesyre |20 | 2930 90 85 | 211513-21-2 | 1-(2-ethylbutyl)-N-(2-sulfanylphenyl)cyclohexancarboxamid |181 | 2930 90 85 | 860035-07-0 | 1-{[(methylsulfanyl)carbonyl]oxy}ethyl-2-methylpropanoat |396 | 2930 90 85 | 893407-18-6 | 2,2,2-trifluor-1-[4'-(methylsulfonyl)biphenyl-4-yl]ethanon |86 | 2930 90 85 | 60759-00-4 | 3,4-diethoxybenzencarbothioamid |180 | 2930 90 85 | 21048-05-5 | N-methylbenzencarbothiohydrazid |47 | 2931 00 95 | 13682-94-5 | (2-bromethenyl)(trimethyl)silan |46 | 2931 00 95 | 914922-89-7 | (2R,4R)-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-N-methoxy-N,2-dimethyl-7-oxoheptanamid |44 | 2931 00 95 | 914922-88-6 | (2R,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-N-methoxy-N,2-dimethyloct-7-enamid |45 | 2931 00 95 | 871355-80-5 | (4R)-2-brom-7-{[tert-butyl(diphenyl)silyl]oxy}hept-1-en-4-yl 4-methylbenzensulfonat |192 | 2931 00 95 | 89694-48-4 | (5-chlor-2-methoxyphenyl)boronsyre |359 | 2931 00 95 | 701278-08-2 | [(1R,5S)-5-[dimethyl(phenyl)silyl]-2-{[(2-methoxypropan-2-yl)oxy]methyl}cyclopent-2-en-1-yl]methanol |360 | 2931 00 95 | 701278-09-3 | {(4S,5R)-5-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]cyclopent-1-en-1-yl}methanol |318 | 2931 00 95 | 796967-18-5 | 1-(2-fluor-5-methylphenyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea |52 | 2931 00 95 | 172732-52-4 | 2-(1,3,2-dioxaborinan-2-yl)benzonitril |48 | 2931 00 95 | 185411-12-5 | methyl-3-(trimethylsilyl)pent-4-enoat |43 | 2932 19 00 | 253128-10-8 | (1S)-1,5:7,10-dianhydro-12,13-bis-O-[tert-butyl(dimethyl)silyl]-2,3,4,6,8,11-hexadeoxy-1-{2-[(2S,5S)-5-(3-hydroxypropyl)-3-methylidentetrahydrofuran-2-yl]ethyl}-3-methyl-9-O-methyl-4-methyliden-8-[(phenylsulfonyl)methyl]-D-arabino-D-altro-tridecitol |571 | 2932 19 00 | 441045-17-6 | (1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-bis(methylen)-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-on-methansulfonat |35 | 2932 29 85 | 916069-80-2 | (4S)-4-(fluormethyl)dihydrofuran-2(3H)-on |554 | 2932 29 85 | 63106-93-4 | 1-phenyl-3-oxabicyclo[3.1.0]hexan-2-on |140 | 2932 29 85 | 7734-80-7 | 2-oxo-2H-chromen-6-carboxylsyre |399 | 2932 29 85 | 0-00-0 | 4-(4-fluorphenyl)-7-(isothiocyanatomethyl)-2H-chromen-2-on |142 | 2932 29 85 | 947408-91-5 | 6-[(2,4-dihydroxyphenyl)carbonyl]-2H-chromen-2-on |141 | 2932 29 85 | 947408-90-4 | 6-[(2,4-dimethoxyphenyl)carbonyl]-2H-chromen-2-on |165 | 2932 99 00 | 452342-08-4 | (1R)-2-(benzylamino)-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol |206 | 2932 99 00 | 99541-23-8 | (1R,2S,3R,4R,5R)-4-azido-2-{[(4aR,6S,7R,8S,8aR)-7,8-bis(benzyloxy)-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy}-6,8-dioxabicyclo[3.2.1]oct-3-yl acetat |389 | 2932 99 00 | 461432-25-7 | (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[4-chlor-3-(4-ethoxybenzyl)phenyl]-D-glucitol |116 | 2932 99 00 | 196597-79-2 | (2E)-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidenethannitril |550 | 2932 99 00 | 3308-94-9 | 2-(3-chlorpropyl)-2-(4-fluorphenyl)-1,3-dioxolan |568 | 2932 99 00 | 274693-53-7 | [(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]carbamat |61 | 2932 99 00 | 185954-98-7 | [6(2Z,3R)]-3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-(3-metoxydecyl)-6-methyl-2-[(1-oxo-11-octadecenyl)amino]-4-O-phosphono-β-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-α-D-glucopyranose-1-(dihydrogenphosphat)tetranatriumsalt |203 | 2932 99 00 | 136172-58-2 | 1,6-di-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-D-glucopyranose |115 | 2932 99 00 | 196597-80-5 | 2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethanaminhydrochlorid |354 | 2932 99 00 | 666860-59-9 | 2-amino-2-oxoethyl{3-[trans-5-(6-methoxynaphthalen-1-yl)-1,3-dioxan-2-yl]propyl}carbamat |576 | 2932 99 00 | 117661-72-0 | 5-(chlormethyl)-6-methyl-1,3-benzodioxol |405 | 2932 99 00 | 959624-24-9 | 6-(hydroxymethyl)-4-phenyl-3,4-dihydro-2H-chromen-2-ol |388 | 2932 99 00 | 960404-59-5 | but-2-yn-1,4-diol -- methyl 1-C-[4-chlor-3-(4-ethoxybenzyl)phenyl]-α-D-glucopyranosid (1:1) |13 | 2932 99 00 | 15826-37-6 | dinatrium-5,5'-[(2-hydroxypropan-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromen-2-carboxylat) |28 | 2932 99 00 | 204254-84-2 | ethyl-(3aR,7R,7aR)-2,2-dimethyl-7-[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-benzodioxol-5-carboxylat |205 | 2932 99 00 | 99541-26-1 | methyl-(2S,3S,4S,5S,6S)-6-{[(1S,2S,3S,4R,5R)-3-(acetyloxy)-4-azido-6,8-dioxabicyclo[3.2.1]oct-2-yl]methyl}-4,5-bis(benzyloxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylat |204 | 2932 99 00 | 114869-97-5 | methyl-6-O-acetyl-4-O-(2-O-acetyl-3-O-benzyl-6-methyl-α-L-idopyranuronosyl)-3-O-benzyl-2-{[(benzyloxy)carbonyl]amino}-2-deoxy-α-D-glucopyranosid |478 | 2933 19 90 | 1035677-60-1 | (4S)-3-(4-chlorphenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazol-1-carboximidamid-2,3-dihydroxybutandioat |194 | 2933 19 90 | 18048-64-1 | 2-(3,4-dimethylphenyl)-5-methyl-2,4-dihydro-3H-pyrazol-3-on |477 | 2933 19 90 | 1035675-24-1 | 3-(4-chlorphenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazol-1-carboximidamid |310 | 2933 19 90 | 1028026-83-6 | 5-methyl-1-(propan-2-yl)-4-[4-(propan-2-yloxy)benzyl]-1,2-dihydro-3H-pyrazol-3-on |585 | 2933 19 90 | 473921-12-9 | 5-{[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy}benzen-1,3-dicarbonitril |89 | 2933 29 90 | 65902-59-2 | 2-brom-4-nitro-1H-imidazol |90 | 2933 29 90 | 57531-37-0 | 2-chlor-4-nitro-1H-imidazol |24 | 2933 29 90 | 1000164-35-1 | 3-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidyl-2-methylalanyl-L-α-glutamylglycin |488 | 2933 29 90 | 152074-97-0 | L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonin |489 | 2933 29 90 | 781666-30-6 | L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonintetraacetat |176 | 2933 29 90 | 451470-33-0 | methyl-3'-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)biphenyl-3-carboxylat |348 | 2933 39 99 | 925978-49-0 | (+)-5-[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]-1-azabicyclo[3.2.1]octan |325 | 2933 39 99 | 876170-44-4 | (1S,5S)-3-(5,6-dichlorpyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptanbenzensulfonat |1 | 2933 39 99 | 741705-70-4 | (2R)-phenyl[(2R)-piperidin-2-yl]ethansyrehydrochlorid |162 | 2933 39 99 | 414910-13-7 | (2S)-hydroxy(phenyl)ethansyre -- (2R)-2-(4-fluor-2-methylphenyl)piperidin-4-on (1:1) |314 | 2933 39 99 | 0-00-0 | (3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrrol-4-methylbenzensulfonat |315 | 2933 39 99 | 370882-57-8 | (3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrroldihydrochlorid |121 | 2933 39 99 | 334618-23-4 | (3R)-piperidin-3-amindihydrochlorid |579 | 2933 39 99 | 1062580-52-2 | (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amindihydrochlorid |578 | 2933 39 99 | 27262-47-1 | (S)-1-butyl-N-(2,6-dimethylphenyl)piperidin-2-carboxamid |183 | 2933 39 99 | 105812-81-5 | [(3S,4R)-4-(4-fluorphenyl)-1-methylpiperidin-3-yl]methanol |324 | 2933 39 99 | 876068-51-8 | [(3S,4S)-4-amino-1-(5,6-dichlorpyridin-3-yl)pyrrolidin-3-yl]methanol |408 | 2933 39 99 | 871022-14-9 | 1-({4-[({[2-oxo-3-(propan-2-yl)-2,3-dihydro-1H-benzimidazol-1-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)cyclobutancarboxylsyre |549 | 2933 39 99 | 5421-92-1 | 1-(pyridin-4-yl)pyridiniumchloridhydrochlorid |541 | 2933 39 99 | 272776-12-2 | 1,1'-binaphthalen-2,2'-diol -- 5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazol (1:1) |409 | 2933 39 99 | 871022-19-4 | 1-[(4-{[(tert-butoxycarbonyl)amino]methyl}piperidin-1-yl)methyl]cyclobutancarboxylsyre |414 | 2933 39 99 | 3613-73-8 | 2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol |535 | 2933 39 99 | 179687-79-7 | 2-[(2-chlor-4-nitrophenoxy)methyl]pyridin |201 | 2933 39 99 | 122321-04-4 | 2-[methyl(pyridin-2-yl)amino]ethanol |311 | 2933 39 99 | 945405-37-8 | 2-methyl-3-[(2S)-pyrrolidin-2-ylmethoxy]pyridin-2,3-dihydroxybutandioat |155 | 2933 39 99 | 936637-40-0 | 3,3'-piperidin-1,4-diyldipropan-1-ol 4-methylbenzensulfonat |40 | 2933 39 99 | 88150-62-3 | 3-ethyl-5-methyl-4-(2-chlorphenyl)-2-{[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridin-3,5-dicarboxylat |404 | 2933 39 99 | 84100-54-9 | 4-(ethylamino)piperidin-4-carboxamid |157 | 2933 39 99 | 873546-30-6 | 4,4'-[piperidin-1,4-diylbis(propan-3,1-diyloxy)]bis(N'-hydroxybenzencarboximidamid) |158 | 2933 39 99 | 873546-74-8 | 4,4'-[piperidin-1,4-diylbis(propan-3,1-diyloxy)]bis[N'-(acetyloxy)benzencarboximidamid] |159 | 2933 39 99 | 873546-38-4 | 4,4'-[piperidin-1,4-diylbis(propan-3,1-diyloxy)]dibenzencarboximidamidtrihydrochloridpentahydrat |156 | 2933 39 99 | 873546-80-6 | 4,4'-[piperidin-1,4-diylbis(propan-3,1-diyloxy)]dibenzonitril |316 | 2933 39 99 | 78750-61-5 | 4-[(3-nitropyridin-2-yl)amino]phenol |87 | 2933 39 99 | 866109-93-5 | 4-{4-[4-(trifluormethoxy)phenoxy]piperidin-1-yl}phenol 4-methylbenzensulfonat |472 | 2933 39 99 | 927889-51-8 | 4-brom-2,6-diethylpyridin-4-methylbenzensulfonat |272 | 2933 39 99 | 691882-47-0 | 4-hydroxybenzoesyre -- (2S,4E)-N-methyl-5-[5-(propan-2-yloxy)pyridin-3-yl]pent-4-en-2-amin (1:1) |323 | 2933 39 99 | 876068-46-1 | 5,6-dichlor-N-(2,2-dimethoxyethyl)pyridin-3-amin |220 | 2933 39 99 | 1072-98-6 | 5-chlorpyridin-2-amin |85 | 2933 39 99 | 298692-34-9 | 6-(chloracetyl)pyridin-2-carboxylsyre |349 | 2933 39 99 | 550349-58-1 | 7-chlor-3-(6-methoxypyridin-3-yl)-N,N,5-trimethyl-4-oxo-4,5-dihydro-3H-pyridazino[4,5-b]indol-1-carboxamid |160 | 2933 39 99 | 414909-98-1 | benzyl 2-(4-fluor-2-methylphenyl)-4-oxo-3,4-dihydropyridin-1(2H)-carboxylat |164 | 2933 39 99 | 56880-11-6 | ethyl-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl)acetat |273 | 2933 39 99 | 548797-97-3 | N-(2-{[(2S)-3-{[1-(4-chlorbenzyl)piperidin-4-yl]amino}-2-hydroxy-2-methylpropyl]oxy}-4-hydroxyphenyl)acetamid |352 | 2933 39 99 | 0-00-0 | N-[(S)-1-azabicyclo[2.2.2]oct-2-yl(phenyl)methyl]-2,6-dichlor-3-(trifluormethyl)benzamidhydrochlorid |289 | 2933 39 99 | 329003-65-8 | natriumhydrogen[1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonathemipentahydrat |58 | 2933 49 10 | 417716-92-8 | 4-{3-chlor-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinolin-6-carboxamidmethansulfonat |584 | 2933 49 90 | 503291-53-0 | 2-ethylbutyl (3S,4aS,6S,8aR)-6-[3-chlor-2-(1H-tetrazol-5-yl)phenoxy]decahydro-3-isoquinolincarboxylat 4-methylbenzensulfonat |539 | 2933 49 90 | 103733-32-0 | benzyl-(3S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-3-carboxylathydrochlorid |581 | 2933 49 90 | 503293-98-9 | (3S,4aS,6S,8aR)-6-hydroxy-2-(methoxycarbonyl)decahydroisoquinolin-3-carboxylsyre |583 | 2933 49 90 | 503290-66-2 | (3S,4aS,6S,8aR)-6-[3-chlor-2-(2H-tetrazol-5-yl)phenoxy]decahydro-3-isoquinolincarboxylisyrehydrochlorid |580 | 2933 49 90 | 134388-95-7 | (3S,4aS,8aR)-2-(methoxycarbonyl)-6-oxodecahydroisoquinolin-3-carboxylsyre -- (1R)-1-phenylethanamin (1:1) |328 | 2933 49 90 | 868210-14-4 | 4-(4-{[(2S,4R)-4-[acetyl(4-chlorphenyl)amino]-2-methyl-3,4-dihydroquinolin-1(2H)-yl]carbonyl}phenoxy)-2,2-dimethylbutansyre |545 | 2933 49 90 | 00-00-0 | methyl 2-[(3R)-3-{3-[(E)-2-(7-chlorquinolin-2-yl)ethenyl]phenyl}-3-({[1-(hydroxymethyl)cyclopropyl]methyl}sulfanyl)propyl]benzoathydrochlorid |534 | 2933 49 90 | 848133-76-6 | N-(4-chlor-3-cyan-7-ethoxyquinolin-6-yl)acetamid |479 | 2933 59 95 | 869490-23-3 | (3,3-difluorpyrrolidin-1-yl){(2S,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl}methanon |421 | 2933 59 95 | 941685-40-1 | (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propannitril |416 | 2933 59 95 | 941678-49-5 | (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propannitril |420 | 2933 59 95 | 941685-41-2 | (3S)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propannitril |394 | 2933 59 95 | 957187-34-7 | [(8R)-8-(3,5-difluorphenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]eddikesyre |190 | 2933 59 95 | 356058-42-9 | {2-[(4-fluorbenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}eddikesyre |395 | 2933 59 95 | 0-00-0 | 2,3-dihydroxy-2,3-bis(phenylcarbonyl)butandisyre – ethyl-[(8R)-8-(3,5-difluorphenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]acetat (1:1) |407 | 2933 59 95 | 90213-66-4 | 2,4-dichlor-7H-pyrrolo[2,3-d]pyrimidin |197 | 2933 59 95 | 3934-20-1 | 2,4-dichlorpyrimidin |189 | 2933 59 95 | 451487-18-6 | 2-[(4-fluorbenzyl)sulfanyl]-1,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-on |120 | 2933 59 95 | 865758-96-9 | 2-[(6-chlor-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]benzonitril |340 | 2933 59 95 | 934815-71-1 | 2-[3-(6-{[2-(2,4-dichlorphenyl)ethyl]amino}-2-methoxypyrimidin-4-yl)phenyl]-2-methylpropansyrephosphat |278 | 2933 59 95 | 722543-31-9 | 2-{ethyl[3-({4-[(5-{2-[(3-fluorphenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino}ethyldihydrogenphosphat |361 | 2933 59 95 | 1032066-96-8 | 2-amino-9-{(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]-2-methylidencyclopentyl}-1,9-dihydro-6H-purin-6-on -- methansulfonat (2:1) |406 | 2933 59 95 | 540737-29-9 | 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropannitril-2-hydroxypropan-1,2,3-tricarboxylat |400 | 2933 59 95 | 1137917-12-4 | 3-{[6-(ethylsulfonyl)pyridin-3-yl]oxy}-5-{[(2S)-1-hydroxypropan-2-yl]oxy}benzoesyre -- 1,4-diazabicyclo[2.2.2]octan (2:1) |422 | 2933 59 95 | 941685-39-8 | 3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propannitril |419 | 2933 59 95 | 941685-27-4 | 4-(1H-pyrazol-4-yl)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin |365 | 2933 59 95 | 1780-26-3 | 4,6-dichlor-2-methylpyrimidin |567 | 2933 59 95 | 145783-14-8 | 4,6-dichlor-5-nitro-2-(propylsulfanyl)pyrimidin |423 | 2933 59 95 | 3680-69-1 | 4-chlor-7H-pyrrolo[2,3-d]pyrimidin |215 | 2933 59 95 | 61379-64-4 | 4-cyclopentylpiperazin-1-amin |219 | 2933 59 95 | 55112-42-0 | 4-methylpiperazin-1-carbonylchloridhydrochlorid |338 | 2933 59 95 | 0-00-0 | 5-(benzylamino)-2-(3-methoxyphenyl)-7-(4-methylpiperazin-1-yl)[1,2,4]triazolo[1,5-a]quinolin-4-carbonitril -- (2E)-but-2-endioat (2:1) hydrat |471 | 2933 59 95 | 55293-96-4 | 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-carbaldehyd |288 | 2933 59 95 | 179688-01-8 | 7-(benzyloxy)-6-methoxyquinazolin-4(3H)-on |198 | 2933 59 95 | 444731-74-2 | N-(2-chlorpyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amin |355 | 2933 59 95 | 0-00-0 | N-(5-fluor-3-methyl-1H-indol-1-yl)-4-methyl-2-(pyridin-2-yl)pyrimidin-5-carboxamid |484 | 2933 79 00 | 586414-48-4 | (-)-3-{3-brom-4-[(2,4-difluorbenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamid |486 | 2933 79 00 | 425663-71-4 | (1S)-1-amino-3-methyl-1,3,4,5-tetrahydro-2H-3-benzazepin-2-on-hydrochlorid |34 | 2933 79 00 | 813452-14-1 | (4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-3-yl]-4-(fluormethyl)pyrrolidin-2-on-dihydrochlorid |77 | 2933 79 00 | 5162-90-3 | 3-(2-oxo-1,2-dihydroquinolin-4-yl)alanin |384 | 2933 79 00 | 536760-29-9 | 3-chlor-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-on |78 | 2933 79 00 | 4876-10-2 | 4-(brommethyl)quinolin-2(1H)-on |69 | 2933 79 00 | 5057-12-5 | 4,6,7,8-tetrahydroquinolin-2,5(1H,3H)-dion |72 | 2933 79 00 | 54197-66-9 | 6-hydroxy-3,4-dihydroquinolin-2(1H)-on |75 | 2933 79 00 | 22246-18-0 | 7-hydroxy-3,4-dihydroquinolin-2(1H)-on |380 | 2933 79 00 | 536759-91-8 | ethyl-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3-carboxylat |382 | 2933 79 00 | 503614-91-3 | ethyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3-carboxylat |485 | 2933 79 00 | 586379-61-5 | methyl-3-(4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoat |368 | 2933 99 80 | 709031-45-8 | (1S,3S,5S)-2-azabicyclo[3.1.0]hexan-3-carboxamidmethansulfonat |376 | 2933 99 80 | 649735-46-6 | (2R)-1-({4-[(4-fluor-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-ol |276 | 2933 99 80 | 51077-14-6 | (2S)-1-(tert-butoxycarbonyl)azetidin-2-carboxylsyre |277 | 2933 99 80 | 631916-97-7 | (2S)-N-{4-[(Z)-amino(methoxyimino)methyl]benzyl}-1-{(2R)-2-[3-chlor-5-(difluormethoxy)phenyl]-2-hydroxyethanoyl}azetidin-2-carboxamid -- benzensulfonsyre (1:1) |564 | 2933 99 80 | 80875-98-5 | (2S,3aS,7aS)-octahydro-1H-indol-2-carboxylsyre |313 | 2933 99 80 | 948846-40-0 | (2S,3S)-2,3-bis[(phenylcarbonyl)oxy]butandisyre – ethyl-(3aR,6aR)-hexahydropyrrolo[3,4-b]pyrrol-5(1H)-carboxylat (1:1) |302 | 2933 99 80 | 1000164-36-2 | (5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S)-5-(3-amino-3-oxopropyl)-20-benzyl-23-[(2S)-butan-2-yl]-14,38-bis{4-[(tert-butoxycarbonyl)amino]butyl}-29-{[1-(tert-butoxycarbonyl)-1H-indol-3-yl]methyl}-17-(3-tert-butoxy-3-oxopropyl)-1-(1H-fluoren-9-yl)-8,11,26,41,41-pentamethyl-32-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-35-(propan-2-yl)-2-oxa-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaazadotetracontan-42-syre |529 | 2933 99 80 | 22162-51-2 | 1-(2-nitrobenzyl)-1H-pyrrol-2-carbaldehyd |410 | 2933 99 80 | 35681-40-4 | 1-(propan-2-yl)-1,3-dihydro-2H-benzimidazol-2-on |522 | 2933 99 80 | 166170-15-6 | 1-(tert-butoxycarbonyl)-2-methyl-D-prolin |322 | 2933 99 80 | 796967-16-3 | 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluor-5-methylphenyl)urea |321 | 2933 99 80 | 0-00-0 | 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluor-5-methylphenyl)ureahydrochlorid |196 | 2933 99 80 | 444731-72-0 | 2,3-dimethyl-2H-indazol-6-amin |415 | 2933 99 80 | 19686-05-6 | 2,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol |524 | 2933 99 80 | 912444-00-9 | 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazol-4-carboxamid |523 | 2933 99 80 | 912445-36-4 | 2-[(2S)-2-methylpyrrolidin-2-yl]-1H-benzimidazol-4-carboxamiddihydrochlorid |481 | 2933 99 80 | 163457-23-6 | 3,3-difluorpyrrolidinhydrochlorid |65 | 2933 99 80 | 239463-85-5 | 3-{5-[(2R)-2-aminopropyl]-7-cyan-2,3-dihydro-1H-indol-1-yl}propylbenzoat-(2R,3R)-2,3-dihydroxybutandioat |150 | 2933 99 80 | 55321-99-8 | 3-oxo-3,4-dihydropyrazin-2-carboxamid |375 | 2933 99 80 | 952490-01-6 | 4-[(4-fluor-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoat |274 | 2933 99 80 | 942436-93-3 | 4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnolin-3-carboxamid |275 | 2933 99 80 | 942437-37-8 | 4-amino-8-(2-fluor-6-methoxyphenyl)-N-propylcinnolin-3-carboxamid |285 | 2933 99 80 | 288385-88-6 | 4-fluor-2-methyl-1H-indol-5-ol |582 | 2933 99 80 | 503293-47-8 | 5-(2-chlor-6-fluorphenyl)-2H-tetrazol |71 | 2933 99 80 | 73963-42-5 | 5-(4-chlorbutyl)-1-cyclohexyl-1H-tetrazol |271 | 2933 99 80 | 606143-52-6 | 5-[(4-brom-2-chlorphenyl)amino]-4-fluor-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazol-6-carboxamid |347 | 2933 99 80 | 0-00-0 | 5-fluor-1-(3-fluorbenzyl)-N-(1H-indol-5-yl)-1H-indol-2-carboxamid |373 | 2933 99 80 | 872206-47-8 | 5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl-2,2-dimethylpropanoat |151 | 2933 99 80 | 259793-88-9 | 6-brom-3-oxo-3,4-dihydropyrazin-2-carboxamid |562 | 2933 99 80 | 1137606-74-6 | 6-fluor-3-oxo-3,4-dihydropyrazin-2-carbonitril -- N-cyclohexylcyclohexanamin (1:1) |482 | 2933 99 80 | 261953-36-0 | 6-iod-1H-indazol |73 | 2933 99 80 | 80076-47-7 | 8,9-difluor-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinolin-2-carboxylsyre |188 | 2933 99 80 | 52602-39-8 | 9H-carbazol-4-ol |235 | 2933 99 80 | 145641-35-6 | benzyl-(2S,3aR,7aS)-octahydro-1H-indol-2-carboxylathydrochlorid |540 | 2933 99 80 | 87269-87-2 | benzyl-(2S,3aS,6aS)-octahydrocyclopenta[b]pyrrol-2-carboxylathydrochlorid |21 | 2933 99 80 | 1012065-72-3 | ethyl-2-amino-9,10-dimethoxy-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isoquinolin-3-carboxylat |563 | 2933 99 80 | 131707-24-9 | ethyl-6-brom-5-hydroxy-1-methyl-2-[(phenylsulfanyl)methyl]-1H-indol-3-carboxylat |124 | 2933 99 80 | 105152-95-2 | ethyl-7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorphenyl)-6-fluor-4-oxo-1,4-dihydro-1,8-naphthyridin-3-carboxylat |117 | 2933 99 80 | 139481-44-0 | methyl-1-[(2'-cyanbiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazol-7-carboxylat |393 | 2933 99 80 | 0-00-0 | methyl-1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-b]pyridin-3-carboxylat |555 | 2933 99 80 | 21688-11-9 | N2-[(benzyloxy)carbonyl]-L-glutaminyl-L-asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamid |370 | 2933 99 80 | 361440-67-7 | tert-butyl-(1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexan-2-carboxylat |371 | 2933 99 80 | 709031-38-9 | tert-butyl-(2S)-2-carbamoyl-2,3-dihydro-1H-pyrrol-1-carboxylat |366 | 2933 99 80 | 709031-43-6 | tert-butyl-[(1S)-2-[(1S,3S,5S)-3-cyan-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-oxoethyl]carbamat |588 | 2933 49 90 | 936359-25-0 | methyl-2-((R)-3-(3-((E)-2-(7-chlorquinolin-2-yl)vinyl)phenyl)-3-(((1-(hydroxymethyl)cyclopropyl)methyl)sulfanyl)propyl)benzoat |341 | 2934 10 00 | 110130-88-6 | (2Z)-[(acetyloxy)imino](2-amino-1,3-thiazol-4-yl)ethansyre |547 | 2934 10 00 | 68672-66-2 | (2Z)-{[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy]imino}[2-(tritylamino)-1,3-thiazol-4-yl]ethansyre |202 | 2934 10 00 | 291536-35-1 | (5Z)-5-(4-fluorbenzyliden)-1,3-thiazolidin-2,4-dion |362 | 2934 10 00 | 302964-24-5 | 2-amino-N-(2-chlor-6-methylphenyl)-1,3-thiazol-5-carboxamid |339 | 2934 10 00 | 866920-24-3 | 3-[2-chlor-4-({4-methyl-2-[4-(trifluormethyl)phenyl]-1,3-thiazol-5-yl}methoxy)phenyl]-1,2,4-oxadiazol-5(4H)-on |353 | 2934 10 00 | 752253-39-7 | 4-(2-chlor-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluor-4-methylphenyl)ethyl]-5-methyl-N-(prop-2-yn-1-yl)-1,3-thiazol-2-amin |57 | 2934 10 00 | 914361-45-8 | L-lysin -- {[(2R,3R)-3-[4-(4-cyanphenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorphenyl)-1-(1H-1,2,4-triazol-1- yl)butan-2-yl]oxy}methyldihydrogenphosphat -- ethanol (1:1:1) |363 | 2934 10 00 | 302964-08-5 | N-(2-chlor-6-methylphenyl)-2-[(6-chlor-2-methylpyrimidin-4-yl)amino]-1,3-thiazol-5-carboxamid |107 | 2934 10 00 | 127660-04-2 | natrium-(2Z)-(2-amino-1,3-thiazol-4-yl)(hydroxyimino)ethanoat |135 | 2934 99 90 | 17381-54-3 | (1-benzothiophen-5-yl)eddikesyre |60 | 2934 99 90 | 630100-90-2 | (1R)-1,2-anhydro-4-C-{(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carboxylato-4-cycloheptylpiperazin-2-yl)-6,9-dihydroxy-2,6-dimethyl-11-oxooxacyclododec-3-en-1-yl]penta-1,3-dien-1-yl}-3,5-dideoxy-1-[(2R,3S)-3-hydroxypentan-2-yl]-D-erythropentitol |283 | 2934 99 90 | 220099-91-2 | (2R)-3'H-spiro[4-azabicyclo[2.2.2]octan-2,2'-furo[2,3-b]pyridin] |282 | 2934 99 90 | 220100-81-2 | (2R)-3'H-spiro[4-azabicyclo[2.2.2]octan-2,2'-furo[2,3-b]pyridin] (S,S)-2,3-dihydroxybutandioat |29 | 2934 99 90 | 161599-46-8 | (2R,3R,4R,5R)-2-(4-amino-5-fluor-2-oxopyrimidin-1(2H)-yl)-2-fluor-5-methyltetrahydrofuran-3,4-diyldiacetat |30 | 2934 99 90 | 690270-65-6 | (2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-{[(2-methylpropanoyl)oxy]methyl}tetrahydrofuran-3,4-diylbis(2-methylpropanoat)hydrochlorid |392 | 2934 99 90 | 265121-04-8 | (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluormethyl)phenyl]ethoxy}-3-(2-fluorphenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonsyre -- 1-deoxy-1-(methylamino)-D-glucitol (1:2) |126 | 2934 99 90 | 163680-80-6 | (3S)-10-[1-(acetylamino)cyclopropyl]-9-fluor-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-6-carboxylsyre |544 | 2934 99 90 | 132335-46-7 | (3S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amin |345 | 2934 99 90 | 133413-70-4 | (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,16,22,24-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosan-2,5,8,11,14,17,20,23-octon |169 | 2934 99 90 | 503068-36-8 | (5R)-3-(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-on |166 | 2934 99 90 | 452339-73-0 | (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-on |470 | 2934 99 90 | 877130-28-4 | (6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-on |543 | 2934 99 90 | 132335-44-5 | (S)-3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol |31 | 2934 99 90 | 812647-80-6 | {(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-bis[(phenylcarbonyl)oxy]tetrahydrofuran-2-yl}methyl 3-chlorbenzoat |551 | 2934 99 90 | 00-00-0 | 1-(1-{4-[2-(4-fluorphenyl)-1,3-dioxolan-2-yl]butyl}-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol-2-on |418 | 2934 99 90 | 1029716-44-6 | 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol |358 | 2934 99 90 | 165172-60-1 | 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidin-2,4(1H,3H)-dion -- 1-methylpyrrolidin-2-on (1:1) |139 | 2934 99 90 | 519187-97-4 | 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-3-azetidinol -- (2Z)-2-butendioat (1:1) |49 | 2934 99 90 | 127000-90-2 | 1-{[(2R,3S)-2-(2,4-difluorphenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazol |332 | 2934 99 90 | 710281-33-7 | 2-({[(1R,3S)-3-{[2-(3-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methoxy}cyclohexyl]oxy}methyl)-6-methylbenzoesyre |136 | 2934 99 90 | 96803-30-4 | 2-(1-benzothiophen-5-yl)ethanol |59 | 2934 99 90 | 913695-00-8 | 2-[({4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethylpyridin-2-yl}methyl)sulfinyl]-1H-benzimidazol, natriumsalt (1:1) |286 | 2934 99 90 | 376608-74-1 | 2-{[(3aR,4S,6R,6aS)-6-{[5-amino-6-chlor-2-(propylsulfanyl)pyrimidin-4-yl]amino}-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy}ethanol |55 | 2934 99 90 | 474554-48-8 | 2-brom-1-[3-tert-butyl-4-methoxy-5-(morpholin-4-yl)phenyl]ethanon |148 | 2934 99 90 | 530141-72-1 | 3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-[(3-hydroxy-1,2-benzoxazol-6-yl)methoxy]phenyl)propansyre |138 | 2934 99 90 | 519188-55-7 | 3-[2-(1-benzothiophen-5-yl)ethoxy]-1-(3-hydroxyazetidin-1-yl)propan-1-on |137 | 2934 99 90 | 519188-42-2 | 3-[2-(1-benzothiophen-5-yl)ethoxy]propionsyre |566 | 2934 99 90 | 753015-42-8 | 3-{(E)-2-[(3R)-pyrrolidin-3-yl]ethenyl}-5-(tetrahydro-2H-pyran-4-yloxy)pyridin |557 | 2934 99 90 | 26638-53-9 | 3-chlor-6-methyldibenzo[c,f][1,2]thiazepin-11(6H)-on-5,5-dioxid |153 | 2934 99 90 | 499785-81-8 | 3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3,4-dihydropyrazin-2-carboxamid |154 | 2934 99 90 | 356782-84-8 | 3-oxo-4-(β-D-ribofuranosyl)-3,4-dihydropyrazin-2-carboxamid |211 | 2934 99 90 | 6504-57-0 | 4-[3-hydroxy-3-phenyl-3-(thiophen-2-yl)propyl]-4-methylmorpholin-4-iummethylsulfat |329 | 2934 99 90 | 871484-32-1 | 4-[4-({3-[(4-deoxy-4-fluor-b-D-glucopyranosyl)oxy]-5-(propan-2-yl)-1H-pyrazol-4-yl}methyl)phenyl]-N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]butanamid |575 | 2934 99 90 | 166964-09-6 | 4-chlor-3-methyl-1,2-oxazol-5-amin |93 | 2934 99 90 | 655233-39-3 | 4-nitrobenzyl(6R,7R)-7-amino-8-oxo-3-[(2S)-tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carboxylathydrochlorid |542 | 2920 90 85 | 89729-09-9 | 5,7-dioxa-6-thiaspiro[2.5]octan-6-oxid |172 | 2934 99 90 | 388082-75-5 | 5-[4-[[3-chlor-4-[(3-fluorphenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyd -- 4-methylbenzensulfonat (1:1) |134 | 2934 99 90 | 4923-87-9 | 5-brom-1-benzothiophen |146 | 2934 99 90 | 947408-95-9 | 6-(brommethyl)-2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on |145 | 2934 99 90 | 947408-94-8 | 6-methyl-2-trityl-1,2-benzoxazol-3(2H)-on |110 | 2934 99 90 | 67978-05-6 | diphenylmethyl(2R)-3-methyl-2-[(1R,5S)-3-(4-methylphenyl)-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl]but-3-enoat |357 | 2934 99 90 | 1001859-46-6 | DNA (syntetisk plasmidvektor pCOR, som udtrykker et fusionsprotein af humant interferon beta signalpeptid og 21-154 af human sur fibroblast-vækstfaktor) |326 | 2934 99 90 | 665058-78-6 | DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-A-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-Gsp- T-sp-C-G-sp-T-sp-T) |401 | 2934 99 90 | 923591-06-4 | methyl-(5R,7S,10S)-10-tert-butyl-15,15-dimethyl-3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-1H,5H-2,23:5,8-dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosin-7(3H)-carboxylat |577 | 2934 99 90 | 59337-92-7 | methyl-3-(chlorsulfonyl)thiophen-2-carboxylat |147 | 2934 99 90 | 947409-01-0 | methyl-3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on- 6-yl)methoxy]phenyl]propionat |212 | 2934 99 90 | 85006-31-1 | methyl-3-amino-4-methylthiophen-2-carboxylat |280 | 2934 99 90 | 893428-72-3 | N-(5-chlor-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamin -- (2E)-2-butendioat (1:2) |18 | 2934 99 90 | 390800-88-1 | N,N',N''-(boroxin-2,4,6-triyltris{[(1S)-3-methylbutan-1,1-diyl]imino[(2S)-1-oxo-3-phenylpropan-1,2-diyl]})tripyrazin-2-carboxamid |99 | 2934 99 90 | 112913-94-7 | N-{[4-(4-fluorbenzyl)morpholin-2-yl]methyl}acetamid |412 | 2934 99 90 | 120788-03-6 | S-[(1R,3S)-1-oxidotetrahydrothiophen-3-yl] ethanthioat |402 | 2935 00 90 | 1198178-65-2 | (1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropanaminium-4-methylbenzensulfonat |556 | 2935 00 90 | 39570-96-2 | (2R)-3-(benzylsulfanyl)-N-[(2S)-1-{[(2S,3S)-1-hydrazinyl-3-methyl-1-oxopentan-2-yl]amino}- 3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-2-{[(4-methylphenyl)sulfonyl]amino}propanamid |79 | 2935 00 90 | 24310-36-9 | 1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-on |346 | 2935 00 90 | 0-00-0 | 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinolin-7-sulfonamid-di[(2E)-but-2-endioat]-hydrat |281 | 2935 00 90 | 941690-55-7 | 3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]quinolin-4-carboxamid |199 | 2935 00 90 | 6973-09-7 | 5-amino-2-methylbenzensulfonamid |82 | 2935 00 90 | 193686-76-9 | 7-chlor-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-on |130 | 2935 00 90 | 123664-84-6 | N-(5-methoxy-2-phenoxyphenyl)methansulfonamid |133 | 2935 00 90 | 149457-03-4 | N-[4-(N-formylglycyl)-5-hydroxy-2-phenoxyphenyl]methansulfonamid |132 | 2935 00 90 | 149456-98-4 | N-[4-(N-formylglycyl)-5-methoxy-2-phenoxyphenyl]methansulfonamid |319 | 2935 00 90 | 141450-48-8 | N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-methoxybenzensulfonamidhydrochlorid |391 | 2935 00 90 | 289042-10-0 | N-{5-[(diphenylphosphoryl)methyl]-4-(4-fluorphenyl)-6-(propan-2-yl)pyrimidin-2-yl}-N-methylmethansulfonamid |187 | 2939 99 00 | 7689-03-4 | (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-3,14(4H,12H)-dion |239 | 2939 99 00 | 477-29-2 | colchicosid |173 | 2940 00 00 | 604-69-3 | 1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose |333 | 2940 00 00 | 647834-15-9 | 2-(4-methoxybenzyl)thiophen-3-yl-β-D-glucopyranosid |127 | 2941 90 00 | 76610-92-9 | (6R,7R)-7-({N-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-D-threonyl}amino)-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carboxylsyre |570 | 3907 20 99 | 913976-27-9 | poly(oxy-1,2-ethandiyl), α-hydro-ω-methoxy, diester med 21N6, 21’N6-[[(N2, N6-dicarboxy-L-lysyl-β-alanyl)imino]bis(1-oxo-2, 1-ethandiyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L-alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-L-isoleucyl-L-threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl-L-glutaminyl-L-prolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamid] cyklisk (6→15), (6’→15’) bis(disulfid) |BILAG IVListe over farmaceutiske mellemstoffer, dvs. stoffer, der bruges til fremstilling af farmaceutiske færdigvarer, der skal slettes på listen over produkter, der er fritaget for told, i bilag 6 til bilag I til forordning (EØF) nr. 2658/87, fordi de overføres til listen over produkter, der er fritaget for told, i bilag 3 til bilag I i forordning (EØF) 2658/87KN-kode | CAS RN | Betegnelse |2915 39 00 2937 29 00 | 7753-60-8 | 17-alfa-hydroxy-3,20-dioxopregna-4,9(11)-dien-21-ylacetat se anecortav (INN) |2920 90 85 | 163133-43-5 | 4-(nitrooxy)butyl-(2S)-2-(6-methoxy-2-naphthyl)propanoat se naproxcinod (INN) |2924 29 98 | 194085-75-1 | 2-(2-chlorphenyl)-2-hydroxyethylcarbamat se carisbamat (INN) |2933 39 99 | 103129-82-4 | 3-ethyl-5-methyl-2-[(2-aminoethoxy)methyl]-4-(2-chlorphenyl)-6-methyl-1,4-dihydropyridin-3,5-dicarboxylat se levamlodipin (INN) |2933 39 99 | 319460-85-0 | N-methyl-2-{[3-((E)-2-pyridin-2-ylvinyl)-1H-indazol-6-yl]sulfanyl}benzamid se axitinib (INN) |2934 10 00 | 302962-49-8 | N-(2-chlor-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)thiazol-5-carboxamid se dasatinib (INN) |2934 99 90 | 143491-57-0 | (2R,5S)-4-amino-5-fluor-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-on se emtricitabin (INN) |2934 99 90 | 98819-76-2 | (2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholin se esreboxetin (INN) |2934 99 90 | 475479-34-6 | (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propansyre se aleglitazar (INN) |2934 99 90 | 377727-87-2 | 2-(2-furyl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl}ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[2,3-c]pyrimidin-5-amin se preladenant (INN) |2934 99 90 | 189003-92-7 | 2-{7-fluor-2-oxo-4-[2-(4-thieno[3,2-c]pyridin-4-ylpiperazin-1-yl)ethyl]quinolin-1(2H)-yl}acetamid se trelanserin (INN) |2934 99 90 | 134379-77-4 | 4-amino-5-fluor-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2(1H)-on se dexelvucitabin (INN) |2934 99 90 | 518048-05-0 | kalium-4-[N-(2-fluorbenzyl)carbamoyl]-1-methyl-2-[1-methyl-1-(5-methyl-1,3,4-oxadiazol-2-carboxamido)ethyl]-6-oxo-1,6-dihydropyrimidin-5-olat se raltegravir (INN) |2935 00 90 | 170569-88-7 | 4-[5-(4-fluorphenyl)-3-(trifluormethyl)pyrazol-1-yl]benzen-1-sulfonamid se mavacoxib (INN) |2935 00 90 | 186497-07-4 | N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridin-3-sulfonamid se zibotentan (INN) |[1] EFT L 256 af 7.9.1987, s. 1.